do glp 1 reduce inflammation GLP-1 RAs may lead to a reduction of systemic through Glucagon-like peptide-1: a multi-faceted anti-inflammatory

This is partly due to tirzepatide's mechanism of action as a double agonist, permitting it to assert a more significant decrease in hyperglycemia as compared to glucagon-like peptide (GLP-1) agonists on their own [8]

Decreasing waist circumference with stable or increasing limb measurements suggests favorable fat loss with lean mass preservation

Guirguis says combination treatments such as this could offer additive or synergistic effects meaning that patients have a better chance of responding to at least one of the mechanisms and could experience fewer GI side effects as a result of the dual approach

2024;3(9) doi: 10.1016/j.jacadv.2024.101182

GLP-1 medications are not indicated and would be harmful

We work closely with patients to determine the most appropriate and cost-effective option: All compounded medications we use come from reputable pharmacies that adhere to high quality and safety standards